quinazolines has been researched along with nsc 251635 in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (85.71) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Perez-Soler, R; Sugarman, SM | 1 |
| Chi, DM; Hamel, E; Ho, HH; Shahrik, LK | 1 |
| Atassi, G; Brassinne, C; Coune, A; Frühling, J; Laduron, C; Ruysschaert, JM; Sculier, JP | 1 |
| Brassinne, C; Coune, A; Laduron, C; Sculier, JP | 1 |
| Atassi, G; Brassinne, C; Coune, A; Frühling, J; Ghanem, G; Hildebrand, J; Laduron, C; Ruysschaert, JM; Sculier, JP; Stryckmans, P | 1 |
| Brassinne, C; Coune, A; Frühling, J; Ghanem, G; Hildebrand, J; Laduron, C; Sculier, JP; Verbist, A | 1 |
| Atassi, G; Brassinne, C; Coune, A; Frühling, J; Hildebrand, J; Laduron, C; Penasse, W; Ruysschaert, JM | 1 |
1 review(s) available for quinazolines and nsc 251635
| Article | Year |
|---|---|
Liposomes in the treatment of malignancy: a clinical perspective.
Topics: Acetylmuramyl-Alanyl-Isoglutamine; Adjuvants, Immunologic; Antigens, Neoplasm; Antineoplastic Agents; Clinical Trials as Topic; Doxorubicin; Drug Carriers; Drug Evaluation; Drug Screening Assays, Antitumor; Humans; Immunotherapy; Liposomes; Macrophage Activation; Macrophages; Melanoma-Specific Antigens; Neoplasm Proteins; Neoplasms; Organoplatinum Compounds; Phosphatidylethanolamines; Quinazolines; Treatment Outcome | 1992 |
6 other study(ies) available for quinazolines and nsc 251635
| Article | Year |
|---|---|
Tubulin-dependent hydrolysis of guanosine triphosphate as a screening test to identify new antitubulin compounds with potential as antimitotic agents: application to carbamates of aromatic amines.
Topics: Antineoplastic Agents; Benzimidazoles; GTP Phosphohydrolases; Guanosine Triphosphate; Hydrolysis; Mitosis; Nocodazole; Pyrazines; Quinazolines; Structure-Activity Relationship; Tubulin Modulators | 1989 |
Intravenous infusion of high doses of liposomes containing NSC 251635, a water-insoluble cytostatic agent. A pilot study with pharmacokinetic data.
Topics: Adult; Aged; Antineoplastic Agents; Drug Evaluation; Drug Tolerance; Female; Humans; Infusions, Parenteral; Kinetics; Liposomes; Male; Middle Aged; Neoplasm Metastasis; Neoplasms; Quinazolines; Solubility | 1986 |
High-performance liquid chromatographic determination of 2-[3'-(methoxycarbonylamino)-phenyl]-3-phenyl-6-methoxycarbon ylamino-4-(3H)-quinazolone (NSC-251635) in human serum.
Topics: Antineoplastic Agents; Chromatography, High Pressure Liquid; Humans; Kinetics; Quinazolines; Spectrophotometry, Ultraviolet | 1985 |
Iv administration of a water-insoluble antimitotic compound entrapped in liposomes. Preliminary report on infusion of large volumes of liposomes to man.
Topics: Adenocarcinoma; Adult; Antineoplastic Agents; Carcinoma, Small Cell; Female; Humans; Infusions, Parenteral; Leukemia, Erythroblastic, Acute; Liposomes; Lung Neoplasms; Male; Middle Aged; Neoplasms; Quinazolines | 1983 |
Distribution in man of 111In-labelled liposomes containing a water-insoluble antimitotic agent.
Topics: Antineoplastic Agents; Humans; Indium; Liposomes; Lung Neoplasms; Male; Quinazolines; Radioisotopes; Radionuclide Imaging; Tissue Distribution | 1984 |
Antitumor activity of a water-insoluble compound entrapped in liposomes on L1210 leukemia in mice.
Topics: Animals; Chromatography, Gel; Dose-Response Relationship, Drug; Female; In Vitro Techniques; Injections, Intraperitoneal; Injections, Intravenous; Leukemia L1210; Liposomes; Male; Mice; Mice, Inbred Strains; Neoplasm Transplantation; Quinazolines | 1983 |